Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].

Juszczyk J, Bolewska B, Flieger J, Swietek K, Adamek B, Biskupska-Karasińska M, Dziambor AP, Boroń-Kaczmarska A, Wawrzynowicz-Syczewska M, Cianciara J, Kozłowska J, Daniluk J, Słomka M, Dudziak M, Zaborowski P, Gładysz A, Piszko P, Gonciarz Z, Mazur W, Machniak M, Kryczka W, Zarebska-Michaluk D, Trocha H, Witczak-Malinowska K, Lakomy E, Kuydowicz J, Niwicka-Michałowska A.

Pol Merkur Lekarski. 2001 Oct;11(64):340-3. Polish.

PMID:
11770315
2.

[Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].

Zarebska-Michaluk D, Lebensztejn DM, Kryczka W.

Przegl Epidemiol. 2007;61(3):551-8. Polish.

PMID:
18069393
3.

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.

Hoofnagle JH, Ghany MG, Kleiner DE, Doo E, Heller T, Promrat K, Ong J, Khokhar F, Soza A, Herion D, Park Y, Everhart JE, Liang TJ.

Hepatology. 2003 Jul;38(1):66-74.

PMID:
12829988
4.

24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.

van Leeuwen DJ, Yee LJ, Langner RG.

Am J Gastroenterol. 2002 Feb;97(2):497-8. No abstract available.

PMID:
11866304
5.

Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon.

Fargion S, Bruno S, Borzio M, Battezzati PM, Bissoli F, Ceriani R, Orlandi A, Maraschi A, Chiesa A, Morini L, Fracanzani AL, Crosignani A, Fiorelli G, Podda M.

J Hepatol. 2003 Apr;38(4):499-505.

PMID:
12663243
6.

Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.

Di Marco V, Ferraro D, Almasio P, Vaccaro A, Parisi P, Cappello M, Cino N, Di Stefano R, Craxì A.

J Viral Hepat. 2002 Sep;9(5):354-9.

PMID:
12225330
7.

Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C.

Willson RA.

J Clin Gastroenterol. 2002 Jul;35(1):89-92. Review.

PMID:
12080234
8.

High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.

Sookoian S, Neglia V, Castaño G, Frider B, Kien MC, Chohuela E.

Arch Dermatol. 1999 Aug;135(8):1000-1. No abstract available.

PMID:
10456365
10.

[Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].

Savoye G, Goria O, Herve S, Riachi G, Noblesse I, Bastien L, Courville P, Lerebours E.

Gastroenterol Clin Biol. 2000 Jun-Jul;24(6-7):679. French. No abstract available.

11.

Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.

Sulkowski MS, Wasserman R, Brooks L, Ball L, Gish R.

J Viral Hepat. 2004 May;11(3):243-50.

PMID:
15117326
12.

Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.

Moreno-Monteagudo JA, Castro A, De Pedro A, Lorenzo JA, Fernández-Bermejo M, Lopez S, García-Buey L, Borque MJ, Pedreira JD, Moreno-Otero R.

Aliment Pharmacol Ther. 2002 Feb;16(2):243-9.

13.

Interferon plus ribavirin: a cautionary note.

Macedo G, Ribeiro T.

Am J Gastroenterol. 1999 Oct;94(10):3087-8. No abstract available.

PMID:
10520894
14.

Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy.

Berenguer M, Prieto M, Palau A, Carrasco D, Rayón JM, Calvo F, Berenguer J.

Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1207-12.

PMID:
15489583
15.

[New therapeutic possibilities in chronic hepatitis C].

Criblez DH.

Praxis (Bern 1994). 2000 Mar 9;89(11):450-3. Review. German.

PMID:
10758732
16.

Antiviral action of ribavirin in chronic hepatitis C.

Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, Lonjon I, Castera L, Dhumeaux D.

Gastroenterology. 2004 Mar;126(3):703-14.

PMID:
14988824
17.

[Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists].

Hofmann WP, Bock H, Weber C, Tacke W, Pfaff R, Kihn R, Moog G, Kellner HU, Schöfer M, Frick B, Berg P, Rambow A, Friedrich-Rust M, Herrmann E, Sarrazin C, Zeuzem S.

Z Gastroenterol. 2006 Jan;44(1):25-31. German.

PMID:
16397836
18.

Interferon + ribavirin combination therapy. Open new approach to treatment of patients with hepatitis C virus.

Iino S.

Ital J Gastroenterol Hepatol. 1999 Apr;31(3):216-7. No abstract available.

PMID:
10379483
19.

[Chronic hepatitis C--therapeutic modalities for interferon failure].

Hermann R.

Praxis (Bern 1994). 1998 Oct 14;87(42):1413-20. Review. German.

PMID:
9824949
20.

A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.

Yu ML, Dai CY, Lee LP, Hou NJ, Hsieh MY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL.

Liver Int. 2006 Dec;26(10):1187-95.

PMID:
17105583

Supplemental Content

Support Center